The DOI matches its Crossref record; 14 of the 15 references it cites were found in a registry or an index.
The economic burden of prescription opioid overdose, abuse and dependence in the United States, 2013
Open accessAbstract
Importance: It is important to understand the magnitude and distribution of the economic burden of prescription opioid overdose, abuse, and dependence to inform clinical practice, research, and other decision makers. Decision makers choosing approaches to address this epidemic need cost information to evaluate the cost effectiveness of their choices. Objective: To estimate the economic burden of prescription opioid overdose, abuse, and dependence from a societal perspective. Design, Setting, and Participants: Incidence of fatal prescription opioid overdose from the National Vital Statistics System, prevalence of abuse and dependence from the National Survey of Drug Use and Health. Fatal data are for the US population, nonfatal data are a nationally representative sample of the US civilian noninstitutionalized population ages 12 and older. Cost data are from various sources including health care claims data from the Truven Health MarketScan Research Databases, and cost of fatal cases from the WISQARS (Web-based Injury Statistics Query and Reporting System) cost module. Criminal justice costs were derived from the Justice Expenditure and Employment Extracts published by the Department of Justice. Estimates of lost productivity were based on a previously published study. Exposure: Calendar year 2013. Main Outcomes and Measures: Monetized burden of fatal overdose and abuse and dependence of prescription opioids. Results: The total economic burden is estimated to be $78.5 billion. Over one third of this amount is due to increased health care and substance abuse treatment costs ($28.9 billion). Approximately one quarter of the cost is borne by the public sector in health care, substance abuse treatment, and criminal justice costs. Conclusions and Relevance: These estimates can assist decision makers in understanding the magnitude of adverse health outcomes associated with prescription opioid use such as overdose, abuse, and dependence.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“many of these domains are featured in existing studies of the economic burden of SUDs”
From Monetary conversion factors for economic evaluations of substance use disorders (2017) · cites this paper as Florence et al., 2016
The cited source says what the claim attributes to it.
In the citing paper
“This is a change from previously published estimates, where a large share of costs was attributable to opioid use disorder (Birnbaum et al., 2011; Florence et al., 2016; Rice et al., 2014).”
From The economic burden of opioid use disorder and fatal opioid overdose in the United States, 2017 (2021) · cites this paper as Florence et al., 2016
The cited source says what the claim attributes to it.
In the citing paper
“Matching controlled for basic demographic variables, health status was matched based on the Charlson comorbidity index and health care costs prior to use disorder diagnosis, and regression models controlled for skewness in the expenditure data.”
From The economic burden of opioid use disorder and fatal opioid overdose in the United States, 2017 (2021) · cites this paper as Florence et al., 2016
The cited source says what the claim attributes to it.
In the citing paper
“The original source study used a matched case-control design to estimate the impact of opioid use disorder diagnoses on health care spending.”
From The economic burden of opioid use disorder and fatal opioid overdose in the United States, 2017 (2021) · cites this paper as Florence et al., 2016
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vital signs: overdoses of prescription opioid pain relievers---United States, 1999--2008.
Paulozzi, L. J., Jones, C. M., Mack, K. A., & Rudd, R. A. (2011) · PubMed · Cited by 1,350
Pharmaceutical Overdose Deaths, United States, 2010
Jones, C. M., Mack, K. A., & Paulozzi, L. J. (2013) · JAMA · doi:10.1001/jama.2013.272 · Cited by 678
Societal costs of prescription opioid abuse, dependence, and misuse in the United States
Birnbaum, H. G., White, A. G., Schiller, M., Waldman, T., Cleveland, J. M., & Roland, C. L. (2011) · Pain Medicine · doi:10.1111/j.1526-4637.2011.01075.x · Cited by 644
Vital signs: overdoses of prescription opioid pain relievers---United States, 1999--2008.
(2011) · PubMed · Cited by 640
CDC grand rounds: prescription drug overdoses - a U.S. epidemic.
(2012) · PubMed · Cited by 502
CDC grand rounds: prescription drug overdoses - a U.S. epidemic.
(2012) · PubMed · Cited by 494
Economic Costs of Nonmedical Use of Prescription Opioids
Hansen, R. N., Oster, G., Edelsberg, J., WOODY, G. E., & Sullivan, S. D. (2010) · Clinical Journal of Pain · doi:10.1097/ajp.0b013e3181ff04ca · Cited by 183
Economic Burden of Prescription Opioid Misuse and Abuse
Strassels, S. A. (2009) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2009.15.7.556 · Cited by 148
Estimated Costs of Prescription Opioid Analgesic Abuse in the United States in 2001
Birnbaum, H. G., White, A. G., Reynolds, J. L., Greenberg, P. E., Zhang, M., Vallow, S., Schein, J. R., & Katz, N. P. (2006) · Clinical Journal of Pain · doi:10.1097/01.ajp.0000210915.80417.cf · Cited by 139
Ballesteros, M. F., Webb, K. B., & McClure, R. (2017) · Journal of Safety Research · doi:10.1016/j.jsr.2017.01.001 · Cited by 126
Cited by
Sorted by citations
Items 601–700 of 1,000
Walker, K. S., Bonny, A. E., McKnight, E. R., & Nahata, M. C. (2020) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2019.12.058 · Cited by 8
Zhao, L., Cheng, C., & Bouchard, L. T. (2020) · Obstetrical & Gynecological Survey · doi:10.1097/ogx.0000000000000744 · Cited by 8
Jabourian, A., Dong, F., Mackey, K. E., Vaezazizi, R., Pennington, T. W., & Neeki, M. M. (2020) · Cureus · doi:10.7759/cureus.9567 · Cited by 8
Age as a Mediator of tDCS Effects on Pain: An Integrative Systematic Review and Meta-Analysis
Saldanha, J. S., Zortéa, M., Torres, I. L. D. S., Fregni, F., & Caumo, W. (2020) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2020.568306 · Cited by 8
Abuse-Deterrent Opioid Formulations and the Opioid Crisis: A Pharmacist's Perspective
Gadd, S., Cox, N., Samuelson, J., Kenney, A., Turner, K. M., & Cochran, G. (2020) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0000000000000844 · Cited by 8
Knorr, J. P., Barlow, A., Reinaker, T. S., & Zaki, R. F. (2021) · Clinical Transplantation · doi:10.1111/ctr.14319 · Cited by 8
Sun, T., Aroke, H. A., Kogut, S. J., Katenka, N., Bratberg, J. P., & Buchanan, A. L. (2021) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2021.1981358 · Cited by 8
Improving geographic access to methadone clinics
Bonifonte, A., & Garcia, E. (2022) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2022.108836 · Cited by 8
Physician’s role in prescribing opioids in developing countries
Roa, J. A., Guevara, A., Guevara, C., & Guevara‐Aguirre, J. (2019) · BMJ Case Reports · doi:10.1136/bcr-2018-227072 · Cited by 8
Ridenour, R. M., Kowalski, C., Ba, D. M., Liu, G., Bible, J. E., Garner, M. R., LESLIE, D. L., Aynardi, M. C., & Dhawan, A. (2020) · Foot & Ankle Specialist · doi:10.1177/1938640020977988 · Cited by 8
Opioid use disorder in Germany: healthcare costs of patients in opioid maintenance treatment
Reimer, J., Vogelmann, T., Trümper, D., & Scherbaum, N. (2019) · Substance Abuse Treatment Prevention and Policy · doi:10.1186/s13011-019-0247-9 · Cited by 8
Samuel, A. M., Lovecchio, F. C., Premkumar, A., Vaishnav, A. S., Kim, H. J., & Qureshi, S. A. (2020) · Spine · doi:10.1097/brs.0000000000003861 · Cited by 8
Oliceridine in the Treatment of Moderate to Severe Acute Pain
Eleswarpu, S., & Habib, A. S. (2021) · Pain Management · doi:10.2217/pmt-2020-0087 · Cited by 8
Using an Environmentally Friendly Disposal Bag to Discard Leftover Opioids After Gynecologic Surgery
Boitano, T. K. L., Norton, S. B., Shrestha, K. S., Smith, H. J., Leath, C. A., & Straughn, J. M. (2021) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000004593 · Cited by 8
Laing, B. T., Jayan, A., Erbaugh, L. J., Park, A. S., Wilson, D. J., & Aponte, Y. (2022) · Frontiers in Neural Circuits · doi:10.3389/fncir.2022.977642 · Cited by 8
Knudsen, H. K., Brown, R., Jacobson, N. A., Horst, J., Kim, J., Collier, E., Starr, S., Madden, L. M., Haram, E., & Molfenter, T. D. (2018) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000441 · Cited by 8
Kebbe, M., Sampasa‐Kanyinga, H., Hamilton, H. A., Colman, I., & Chaput, J. (2019) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2019.10.021 · Cited by 8
Townsend, W. B., Worrilow, W. M., Robinson, M. M., Beano, H. M., Parker, B., Gaston, K. E., Clark, P. E., & Riggs, S. B. (2020) · Urology · doi:10.1016/j.urology.2020.04.110 · Cited by 8
Levesque, D., Umanzor, C., & de Aguiar, E. (2018) · JMIR Medical Informatics · doi:10.2196/medinform.7355 · Cited by 7
Danaf, J., Scarpellini, C. D. S., & Montandon, G. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1043581 · Cited by 7
Predictive Models to Assess Risk of Persistent Opioid Use, Opioid Use Disorder, and Overdose
Song, S. L., Dandapani, H. G., Estrada, R. S., Jones, N. W., Samuels, E. A., & Ranney, M. L. (2024) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000001276 · Cited by 9
Genetic Variants Linked to Opioid Addiction: A Genome-Wide Association Study
Panday, S. K., Lyman, R. A., Shankar, V., & Alexov, E. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252312516 · Cited by 7
Buprenorphine's Effect on the Human Immune System and Inflammation
Shin, S. D., Branning, R., McGinnis, M. T., Shin, A. N., Ho, M., Karpyak, V. M., & Oesterle, T. (2025) · Clinical and Translational Science · doi:10.1111/cts.70180 · Cited by 7
Pain Management Testing by Liquid Chromatography Tandem Mass Spectrometry
Bodor, G. S. (2018) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2018.05.005 · Cited by 7
Ji, X., Haight, S. C., Ko, J. Y., Cox, S. N., Barfield, W. D., Zhang, K., Guy, G. P., & Li, R. (2020) · Medical Care · doi:10.1097/mlr.0000000000001475 · Cited by 7
Robertson, M. N., Seitz, H. H., Downey, L. H., Hardman, A. M., Steen, J. S., & Buys, D. R. (2022) · Health Education & Behavior · doi:10.1177/10901981221116778 · Cited by 7
McNamara, C., Laurita, J. T., Lambert, B. S., Sullivan, T. C., Clyburn, T. A., Incavo, S. J., & Park, K. J. (2023) · The Knee · doi:10.1016/j.knee.2023.06.002 · Cited by 7
National Trends in Orthopaedic Pain Management from 2016 to 2020
Peterman, N. J., Shivdasani, K., Pagani, N. R., Mann, R., Naik, A., Pekas, D. R., & Sun, D. C. (2024) · Journal of the American Academy of Orthopaedic Surgeons · doi:10.5435/jaaos-d-23-00806 · Cited by 7
Morphine-Driven m6A Epitranscriptomic Neuroadaptations in Primary Cortical Cultures
Dabrowski, K. R., & Daws, S. E. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04219-z · Cited by 7
Trenchfield, D. R., Fras, S. I., McCurdy, M. T., Narayanan, R., Lee, Y. A., Issa, T. Z., Toci, G. R., Oghli, Y. S., Siddiqui, H., Vo, M., et al. (2024) · Journal of the American Academy of Orthopaedic Surgeons · doi:10.5435/jaaos-d-24-00167 · Cited by 7
Al-Hassan, A., Weissman, B., Chowdhury, S., Sawires, J., & Soti, V. (2025) · Cureus · doi:10.7759/cureus.79759 · Cited by 7
Gorfinkel, L., Giesler, A., Dong, H., Wood, E., Fairbairn, N. S., & Klimas, J. (2019) · JMIR Medical Education · doi:10.2196/12474 · Cited by 7
Siddiqui, M. T. (2019) · Annals of Gastroenterology · doi:10.20524/aog.2019.0389 · Cited by 7
Van, S. P., Yao, A. L., Tang, T., Kott, M., Noles, A., Dabai, N., Coslick, A. M., Rojhani, S., Sprankle, L. A., & Hoyer, E. H. (2019) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2019.04.011 · Cited by 7
Hruschak, V., Hildenbrand, A. K., & Cochran, G. (2019) · Substance Abuse · doi:10.1080/08897077.2019.1621238 · Cited by 7
Glogovac, G., Fitts, J., Henning, J. A., Dixon, T. L., & Laughlin, R. T. (2019) · Foot & Ankle Orthopaedics · doi:10.1177/2473011419891078 · Cited by 7
Decreasing Opioid Prescriptions in Women Undergoing Mastectomy and Breast Reconstruction
Tedesco, D., & Mayo, J. L. (2020) · Pain Management Nursing · doi:10.1016/j.pmn.2020.02.068 · Cited by 7
Pourat, N., O’Masta, B., Chen, X., Lu, C. M., Zhou, W., Daniel, M. G., Hoang, H., & Sripipatana, A. (2020) · PLoS ONE · doi:10.1371/journal.pone.0242407 · Cited by 7
Speaker, P. J. (2021) · Forensic Science International Synergy · doi:10.1016/j.fsisyn.2021.100137 · Cited by 7
Interobserver agreement between emergency clinicians and nurses for Clinical Opiate Withdrawal Scale
Tomaszewski, C., Quenzer, F. C., Corbett, B. M., Lafree, A., Lasoff, D. R., Romo, J., & Mukau, L. (2021) · Journal of the American College of Emergency Physicians Open · doi:10.1002/emp2.12462 · Cited by 7
Effect of Manufacturing Process on the Retention of Abuse-Deterrent Properties of PEO-Matrix Tablets
Rezaei, L., Meruva, S., & Donovan, M. D. (2021) · AAPS PharmSciTech · doi:10.1208/s12249-021-02169-6 · Cited by 7
Pericot‐Valverde, I., Perez, A., Heo, M., Coleman, A., Ortiz, E. G., Merchant, K., Melling, T., & Litwin, A. H. (2022) · Contemporary Clinical Trials Communications · doi:10.1016/j.conctc.2022.100918 · Cited by 7
Patterns of Opioid Usage and Predictors of Utilization Following Endoscopic Skull Base Surgery
Kuan, E. C., Birkenbeuel, J. L., Kovacs, A., Abiri, A., Goshtasbi, K., Lehrich, B. M., Golshani, K. J., Chen, J. W., Cadena, G., & Hsu, F. P. K. (2022) · The Laryngoscope · doi:10.1002/lary.30164 · Cited by 7
New Chronic Opioid Use in Medicaid Patients Following Cholecystectomy
Lockett, M. A., Ward, R. C., McCauley, J. L., Taber, D. J., Gebregziabher, M., Cina, R. A., Basco, W. T., Mauldin, P. D., & Ball, S. J. (2022) · Surgery Open Science · doi:10.1016/j.sopen.2022.05.009 · Cited by 7
Lenert, L. A., Zhu, V. J., Jennings, L. K., McCauley, J. L., Obeid, J. S., Ward, R. C., Hassanpour, S., Marsch, L. A., Hogarth, M. A., Shipman, P., et al. (2022) · JAMIA Open · doi:10.1093/jamiaopen/ooac055 · Cited by 7
Mangual, D., Tresgallo-Parés, R., Ramírez-González, M., Torres-Lugo, N. J., Dones, A. E. R., Rivera-Rodríguez, G., Claudio-Marcano, A. M., & Lojo-Sojo, L. (2022) · JAAOS Global Research and Reviews · doi:10.5435/jaaosglobal-d-22-00055 · Cited by 7
Silverstein, J., Sohail, A. H., Pacheco, T. B. S., Khayat, A., Amodu, L., Cherasard, P. D., Levine, J. L., Goparaju, A., Kella, V., Islam, S., et al. (2023) · Obesity Surgery · doi:10.1007/s11695-023-06794-x · Cited by 7
Langford, W. S., & Feldman, M. P. (2024) · Journal of Regional Science · doi:10.1111/jors.12727 · Cited by 8
Brenton, A., Lee, C., Lewis, K., Sharma, M., Kantorovich, S., Smith, G. A., & Meshkin, B. (2018) · Journal of Pain Research · doi:10.2147/jpr.s139189 · Cited by 7
Caring for Pregnant Women with Opioid Use Disorder
Lee, Y. W., & Saia, K. (2019) · Current Obstetrics and Gynecology Reports · doi:10.1007/s13669-019-0255-9 · Cited by 7
Health Care Utilization and Payments of Postoperative and Drug Abuse-Related Spinal Infections
Alhourani, A., Dietz, N. E., Sharma, M., Ugiliweneza, B., Wang, D., Nuno, M. A., Drazin, D. G., & Boakye, M. (2019) · Spine · doi:10.1097/brs.0000000000003102 · Cited by 7
Han, J. T., Susarla, S. M., Dodson, T. B., & Lang, M. S. (2019) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2019.08.009 · Cited by 7
Comparison of Postoperative Opioid Utilization in an ACDF Cohort
Davison, M. A., Lilly, D. T., Eldridge, C. M., Singh, R., Bagley, C. A., & Adogwa, O. (2020) · Clinical Spine Surgery A Spine Publication · doi:10.1097/bsd.0000000000001053 · Cited by 7
A potential peptide inhibitor of SARS-CoV-2 S and human ACE2 complex
Jaiswal, G., Yaduvanshi, S., & Kumar, V. (2021) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2021.1889665 · Cited by 7
The Influence of the Opioid Epidemic on Firearm Violence in Kentucky Counties
Dittmer, S. J., Davenport, D. L., Oyler, D. R., & Bernard, A. C. (2021) · Journal of Surgical Research · doi:10.1016/j.jss.2021.02.011 · Cited by 7
Morphine Equivalent Total Dosage as Predictor of Adverse Outcomes in Opioid Prescribing
Bonifonte, A., Merchant, R. F., & Deppen, K. (2021) · Pain Medicine · doi:10.1093/pm/pnab249 · Cited by 7
A Predictive Algorithm to Detect Opioid Use Disorder
Lee, C. K., Sharma, M., Kantorovich, S., & Brenton, A. (2018) · Health Services Research and Managerial Epidemiology · doi:10.1177/2333392817747467 · Cited by 7
La crise des overdoses américaines : une menace pour la France ?
Vodovar, D., Langrand, J., Tournier, N., & Mégarbane, B. (2018) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2018.10.389 · Cited by 7
Singh, S., Kiessling, K. A., & Rhodes, J. H. (2020) · Journal of Public Health Management and Practice · doi:10.1097/phh.0000000000001101 · Cited by 7
Bourgeois, H. C., Proteau, R. C., Vielma, C. V., Hartung, D. M., & Irwin, A. N. (2020) · Pain Medicine · doi:10.1093/pm/pnaa075 · Cited by 7
Barton, A. W., Reinhart, C. A., Campbell, C. C., Smith, D. C., & Albarracín, D. (2020) · Addictive Behaviors · doi:10.1016/j.addbeh.2020.106757 · Cited by 7
Perioperative Pain Management in Ambulatory and Inpatient Shoulder Surgery
Zangrilli, J. A., Szukics, P. F., Austin, L. S., & Horneff, J. G. (2021) · JBJS Reviews · doi:10.2106/jbjs.rvw.20.00191 · Cited by 7
De Aquino, J. P., Sofuoglu, M., Stefanovics, E. A., & Rosenheck, R. A. (2020) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2020.1818248 · Cited by 6
Opioid prescribing on discharge to skilled nursing facilities
Hubsky, A. R., Noble, B. N., Hartung, D. M., Tjia, J., Lapane, K. L., & Furuno, J. P. (2020) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.5075 · Cited by 6
Risks of Chronic Preoperative Opioid Use on Distal Radius Surgery Outcomes
Newton, W. N., Sossamon, J. A., Pire, J. R., & Daley, D. N. (2023) · Hand · doi:10.1177/15589447231160206 · Cited by 6
Wilkerson, A. H., Sharma, M., Davis, R. E., Stephens, P. M., Kim, R. W., Bhati, D., & Nahar, V. K. (2023) · BMJ Open · doi:10.1136/bmjopen-2022-066147 · Cited by 6
Strategies for Reducing Perioperative Opioid Use in Foot and Ankle Surgery
Xu, A. L., & Humbyrd, C. J. (2023) · Orthopedic Clinics of North America · doi:10.1016/j.ocl.2023.04.006 · Cited by 6
Khoraminejad, B., Sakowitz, S., Gao, Z., Chervu, N. L., Curry, J., Ali, K., Bakhtiyar, S. S., & Benharash, P. (2024) · Surgery Open Science · doi:10.1016/j.sopen.2024.03.006 · Cited by 6
Quaye, A., DiPalazzo, J., Kostka, K., Richard, J. M., Beers-Mulroy, B., Peck, M. T., Krulee, R., & Zhang, Y. (2024) · Pain Medicine · doi:10.1093/pm/pnae120 · Cited by 6
Opioids and the Otolaryngologist: An Ambulatory Assessment
Mohan, S., & Bhattacharyya, N. (2018) · Otolaryngology · doi:10.1177/0194599818765125 · Cited by 6
Tempalski, B., Cleland, C. M., Williams, L. D., Cooper, H. L. F., & Friedman, S. R. (2018) · Substance Abuse Treatment Prevention and Policy · doi:10.1186/s13011-018-0165-2 · Cited by 6
Current State of the Problem: Opioid Overdose Rates and Deaths
Melton, S. H., & Melton, S. T. (2019) · Current Treatment Options in Psychiatry · doi:10.1007/s40501-019-00174-y · Cited by 6
Ribeiro, Í. A. P., Fernandes, M. A., & Pillon, S. C. (2020) · Revista Brasileira de Enfermagem · doi:10.1590/0034-7167-2020-0279 · Cited by 6
Gopalakrishnan, C., Desai, R. J., Franklin, J. M., Jin, Y., Lii, J., Solomon, D. H., Katz, J. N., Lee, Y., Franklin, P. D., & Kim, S. C. (2021) · Arthritis Care & Research · doi:10.1002/acr.24559 · Cited by 6
Opioids and Injury Deaths: A population-based analysis of the United States from 2006 to 2017
Truong, E. I., Kishawi, S. K., Ho, V. P., Tadi, R. S., Warner, D. F., Claridge, J. A., & Tseng, E. S. (2021) · Injury · doi:10.1016/j.injury.2021.03.018 · Cited by 6
Perlmutter, B. C., Wynia, E., McMichael, J. P., Tu, C., Scheman, J., Simon, R., Walsh, R. M., & Augustin, T. (2021) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2021.06.011 · Cited by 6
Wilkes, J. L., Montalban, J. N., Pringle, B. D., Monroe, D., Miller, A., Zapata, I., Brooks, A. E., & Ross, D. W. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10163460 · Cited by 6
Infectious addictions: Geographies of colliding epidemics
King, B. H., & Rishworth, A. (2021) · Progress in Human Geography · doi:10.1177/03091325211052040 · Cited by 6
A multimodal approach to reducing post‐caesarean opioid use: a quality improvement initiative
Llarena, N. C., Krivanek, K., Yao, M., Kim, D. D., Devarajan, J., Ayad, S. S., & Chiang, E. (2022) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.17094 · Cited by 6
Simonton, A. J., Young, C. C., García, A. A., Bartholomew, J. B., & Brown, R. A. (2022) · Mental health and physical activity · doi:10.1016/j.mhpa.2022.100444 · Cited by 6
Alsultan, M. M., & Guo, J. J. (2022) · PubMed Central · Cited by 6
The intergenerational persistence of opioid dependence: Evidence from administrative data
Ahammer, A., & Halla, M. (2022) · Health Economics · doi:10.1002/hec.4589 · Cited by 6
The Role of Pharmacogenomics in Postoperative Pain Management
Sachtleben, E. P., Rooney, K., Haddad, H. W., Lassiegne, V. L., Boudreaux, M. A., Cornett, E. M., & Kaye, A. D. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2573-6_18 · Cited by 6
Amgott-Kwan, A. T., & Zadina, J. E. (2023) · Neuropharmacology · doi:10.1016/j.neuropharm.2023.109439 · Cited by 6
Marcelo, A. C., Ho, E. K., Hunter, D. J., Hilmer, S. N., Jokanovic, N., Prior, J., Carvalho‐e‐Silva, A. P., & Ferreira, M. L. (2023) · Drugs & Aging · doi:10.1007/s40266-023-01011-x · Cited by 6
Bachhuber, M. A., Nash, D., Southern, W. N., Heo, M., Berger, M. A., Schepis, M., & Cunningham, C. O. (2018) · BMJ Open · doi:10.1136/bmjopen-2017-019559 · Cited by 6
Wong, R., Carroll, W., Muttreja, A., Garcia, V. L., Taub, E. M., & Fernan, A. (2018) · Pain Medicine · doi:10.1093/pm/pny239 · Cited by 6
Working with families impacted by the opioid crisis: Education, best practices, and providing hope
Sapp, A. J., & Hooten, P. (2019) · Archives of Psychiatric Nursing · doi:10.1016/j.apnu.2019.08.013 · Cited by 6
The impact of pretransplant opioid exposure on healthcare utilization and costs in kidney transplant
Wise, B., Wilson, L. Z., Taber, D. J., Pilch, N. A., Rohan, V., & Fleming, J. N. (2020) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2479 · Cited by 6
Loomis, E. A., McNaughton, D. B., & Genord, C. K. (2021) · Pain Management Nursing · doi:10.1016/j.pmn.2021.02.002 · Cited by 6
Olwenyi, O. A., Johnson, S. D., Bidokhti, M. R. M., Thakur, V., Pandey, K., Thurman, M., Acharya, A., Uppada, S. B., Callen, S. E., Giavedoni, L. D., et al. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.1001544 · Cited by 6
DiScala, S., Uritsky, T. J., Brown, M. E., Abel, S., Humbert, N. T., & Naidu, D. (2022) · Journal of Pain & Palliative Care Pharmacotherapy · doi:10.1080/15360288.2022.2149670 · Cited by 6
Sobel, H. G., Goedde, M., Maruti, S., Strout, E. K. H., Wahlberg, E. A., & Kennedy, A. G. (2019) · Academic Psychiatry · doi:10.1007/s40596-019-01069-z · Cited by 6
Within-subject evaluation of interim buprenorphine treatment during waitlist delays
Oleskowicz, T. N., Ochalek, T. A., Peck, K. R., Badger, G. J., & Sigmon, S. C. (2021) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2021.108532 · Cited by 6
Waddimba, A. C., Newman, P. J., Shelley, J. K., McShan, E., Cheung, Z.-O., Gibson, J. N., Bennett, M., & Petrey, L. B. (2021) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2021.09.019 · Cited by 6
Medication-assisted treatment for opioid use disorder.
Paradiso, C. (2019) · doi:10.26616/nioshpub2019133 · Cited by 6
Guiding industry settlements of opioid litigation
Hodge, J. G., & Gostin, L. O. (2019) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2019.1618320 · Cited by 6
Recreational Marijuana Laws and the Use of Opioids: Evidence from NSDUH Microdata
Ali, M. M., McClellan, C. B., Mutter, R. L., & Rees, D. I. (2021) · National Bureau of Economic Research · doi:10.3386/w29087 · Cited by 6
Combinatorial Sensors: An Integrated Approach to Lifestyle Management and Environmental Surveillance
Dhamu, V. N., Banga, I. K., Paul, A., Ganguly, A., Bhide, A., Telang, C., Muthukumar, S., & Prasad, S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822548-6.00044-3 · Cited by 6
Productivity Losses From Substance Use Disorder in the U.S. in 2023
Ghimire, R., Florence, C., & Guy, G. P. (2025) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2025.108102 · Cited by 5
Self-citation
Metadata
- Authors
- Florence, C. S., Zhou, C., Luo, F., & Xu, L.
- Affiliations
- Centers for Disease Control and Prevention (US)
- Venue
- Medical Care
- Published
- 2016-10
- Volume
- 54
- Issue
- 10
- Pages
- 901-906
- ISSN
- 0025-7079 (ISSN-L)
- PMC
- PMC5975355
- OpenAlex
- W2519105412
- Cited by
- 1,152
- References
- 15
- Citations by year
- 2026: 30 · 2025: 41 · 2024: 51 · 2023: 79 · 2022: 125 · 2021: 195 · 2020: 265 · 2019: 185 · 2018: 128 · 2017: 45 · 2016: 5
- FWCI
- 119.97
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Medical Care (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (CC999999)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Healthcare Policy and Management
- Keywords
- prescription opioid overdose, opioid abuse, opioid use disorder, economic burden, social costs, health care costs, criminal justice costs, productivity loss, fatal overdose, opioid epidemic
- MeSH terms
- Absenteeism, Prescription Drug Overuse, Criminal Law, Female, Humans, Male, Opioid-Related Disorders, United States, Health Care Costs, Cost of Illness, Prescription Drug Misuse
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review